Dr A Satya Srinivas, Consultant - Medical Oncologist, HCG Curie City Cancer Center, Vijayawada When it comes to colon cancer, lifestyle decisions can make a significant difference. Although genetics and age are beyond our control, we can take charge of our diet and nutrition to substantially
Dr A Satya Srinivas, Consultant - Medical Oncologist, HCG Curie City Cancer Center, Vijayawada The prevalence of sedentary lifestyles has become a growing concern, leading to an increase in obesity rates among children and adults alike. With the widespread availability of technology, such as smartphones, video
HCG Cancer Centre Bengaluru is proud to announce the launch of the CyberKnife S7 System, a fully automated, AI-driven treatment delivery system with real-time motion adaptation, marking a significant advancement in the treatment of both cancerous and non-cancerous tumors. The system was unveiled by Dr.
Revenue for Q1 FY25 of INR 5,256 million, a growth of 14% (y-o-y) EBITDA for Q1 FY25 of INR 929 million, a growth of 21% (y-o-y) and PAT for Q1 FY25 of INR 121 million, a growth of 59% (y-o-y) HealthCare Global Enterprises Limited (“HCG”), the leader
Dr. Raj Nagarkar, Managing Director and Chief of Surgical Oncology and Robotic Services, HCG Manavata Cancer Centre, Nashik Breast cancer treatment has seen significant advancements in recent years, with robotic surgery emerging as a revolutionary approach. Traditionally, breast cancer surgery often involved larger incisions and longer
HCG Aastha Cancer Centre Ahmedabad successfully hosted the 9th edition of the Oncosurgery Mastercourse (OM 9.0), a masterclass dedicated to the specialized field of salivary gland tumours. Given the surgical demands of salivary gland tumours, which require pinnacle of surgical skills, OM 9.0 aimed to
HCG Cancer Centre Jaipur unveiled an indigenous scalp cooling therapy, making it the first in Rajasthan to offer this revolutionary treatment for chemotherapy patients. This advanced therapy is designed to reduce hair loss and promote quicker hair regrowth due to chemotherapy. This technology was officially
Dr. Raj Nagarkar, Managing Director and Chief of Surgical Oncology and Robotic Services, HCG Manavata Cancer Centre, Nashik Diabetes isn't just about watching sugar intake—it's a serious health concern with far-reaching implications. For women, there's an added risk: diabetes has been linked to an increased chance
HCG Manavata Cancer Centre (HCGMCC) recently achieved a feat with the successful surgical removal of an 8.5kg ovarian tumour, highlighting the exceptional expertise of its surgical team. A 50-year-old female patient from Nashik suffering with hypothyroidism and hypertension, presented with abdominal distension and sudden weight gain over the past
Revenue for Q4 FY24 of INR 4,946 Million, a growth of 12% (y-o-y) and for FY24 of INR 19,121 Million, a growth of 13% (y-o-y) EBITDA for Q4 FY24 of INR 941 Million, a growth of 21% (y-o-y) and EBITDA for FY24 of INR 3,374 Million,
